ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.62
-0.37%
US Tech 100
20,874.00
-1.46%
S&P 500
6,025.99
-0.95%
US Dollar vs CAD
1.42985
0.00%
Bitcoin
96,084.82
-0.48%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Daxor Corporation (DXR) Share Price

Daxor Corporation

Daxor Corporation (DXR)

Dynamic Active Retirement Income ETF
7.46
-0.35
(-4.48%)
Closed February 08 3:00PM
Delayed by 15 minutes
7.55
0.09
(1.21%)
After Hours: 6:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
7.46
Bid
7.19
Ask
8.60
Volume
5,017
7.46 Day's Range 8.05
7.19 52 Week Range 9.9999
Market Cap
36.106M
Previous Close
7.81
Open
7.72
Last Trade
12
@
7.19
Last Trade Time
Financial Volume
US$ 38,109
VWAP
7.596
Average Volume (3m)
17,790
Shares Outstanding
4,840,000
Dividend Yield
-
PE Ratio
187.26
Earnings Per Share (EPS)
0.06
Revenue
163k
Net Profit
281k

About Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Show more

Sector
Surgical,med Instr,apparatus
Industry
Misc Health & Allied Svc,nec
Website
www.daxor.com
Headquarters
Oak Ridge, New Jersey, USA
Founded
2010
Daxor Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DXR. The last closing price for Daxor was US$7.81. Over the last year, Daxor shares have traded in a share price range of US$ 7.19 to US$ 9.9999.

Daxor currently has 4,840,000 shares outstanding. The market capitalization of Daxor is US$37.80 million. Daxor has a price to earnings ratio (PE ratio) of 187.26.

Ask ADVFN Intelligence (AI)

DXR Latest News

More News

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

January 22 2025
Edgar (US Regulatory)

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum

Healthcare Providers Embrace Blood Volume Analysis (BVA) in Nephrology and Heart Failure Outpatient Care Oak Ridge, TN, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the...

December 18 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 10 2024
Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

November 21 2024
Edgar (US Regulatory)

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood...

October 09 2024
GlobeNewswire Inc.

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael...

October 08 2024
GlobeNewswire Inc.

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...

September 27 2024
GlobeNewswire Inc.

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual...

September 19 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.52-6.516290726827.988.117.4637557.85667412CS
4-0.67-8.241082410828.138.887.4649918.12033187CS
12-1.36-15.41950113388.829.98997.4299177908.92914712CS
26-1.12-13.05361305368.589.98997.4299115638.94323587CS
52-0.94-11.19047619058.49.99997.1967668.93795561CS
156-3.56-32.304900181511.0214.557.1150829.70601043CS
260-3.51-31.996353691910.9714.557.1150679.70717123CS

DXR - Frequently Asked Questions (FAQ)

What is the current Daxor share price?
The current share price of Daxor is US$ 7.46
How many Daxor shares are in issue?
Daxor has 4,840,000 shares in issue
What is the market cap of Daxor?
The market capitalisation of Daxor is USD 37.8M
What is the 1 year trading range for Daxor share price?
Daxor has traded in the range of US$ 7.19 to US$ 9.9999 during the past year
What is the PE ratio of Daxor?
The price to earnings ratio of Daxor is 187.26
What is the cash to sales ratio of Daxor?
The cash to sales ratio of Daxor is 322.85
What is the reporting currency for Daxor?
Daxor reports financial results in USD
What is the latest annual turnover for Daxor?
The latest annual turnover of Daxor is USD 163k
What is the latest annual profit for Daxor?
The latest annual profit of Daxor is USD 281k
What is the registered address of Daxor?
The registered address for Daxor is 107 MECO LANE, OAK RIDGE, NEW JERSEY, 37830
What is the Daxor website address?
The website address for Daxor is www.daxor.com
Which industry sector does Daxor operate in?
Daxor operates in the MISC HEALTH & ALLIED SVC,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
144.17M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
84.73M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.3M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.65M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
52.44M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.44M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.2M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
780.46M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
262.79M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
215.16M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
210.78M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
209.04M

Discussion

View Full Feed
arizona1 arizona1 3 minutes ago
Perhaps his enthusiasm will wane in time...

Never! This board is like a drug to freebie MAGAts!
janice shell janice shell 3 minutes ago
What? Are you saying you're sleeping with Trumpty? Not to disappoint, but I strongly suspect the Mushroom is letting him down these days.

He didn't "fight" at all. He flew around in his private jet, lying his head off everywhere he went. And he didn't do nearly as much campaigning as
MasterBlastr MasterBlastr 4 minutes ago
2 Form 13F filed Thursday, institutions dumped out 100% of position

2 Form 13F filed Friday, institutions dumped out 100% of position
AMC
XMaster2023 XMaster2023 4 minutes ago
National priority in Brazil FEDERAL SENATE
BILL
No. 126, OF 2025

Very very soon! Nice DD!

Establishes the Regulatory Framework for Vaccines and High-Cost Medicines Against Cancer in Brazil and creates standards for the development, research, production, d
NWBO
ignatiusrielly35 ignatiusrielly35 5 minutes ago
When I was in a combat zone back in the day  there was this one nebbish that said several times per day that we would all probably be killed. The typical whiner. He was very popular, as you can imagine. Name was Mike, ironically. But at least he was discussing his true pathetic weakness and not bein
AVXL
B402 B402 6 minutes ago
See you'll even lie.....knew you before and talked politics on the JP board, which of course is pay

He complained that as a freebie, he couldn't do that. So I told him about TA. Perhaps his enthusiasm will wane in time...

Thanks for playing :)
oystersnbeer oystersnbeer 6 minutes ago
It’s obvious to anyone that can reason and understand,
that neither reason or understanding are in your wheelhouse.
arizona1 arizona1 7 minutes ago
The dems need to shut the government down for the next four years.
B402 B402 8 minutes ago
I just know what I see....a common sense thing.....You use your talent better on scams....

politics, you're too emotional and too bias.....You fail to separate facts from belief, religion like which is the problem with modern politics.......... Blind to it too

Imho of c
GVInvestments GVInvestments 9 minutes ago
I'm tired of giving musk my tax dollars. Why should we tax payers pay him 19 billion for his crapy rockets.
TSLA
go seek go seek 9 minutes ago
Jay Luly’s personal ENTA holding has dropped $60M in value since October. Motivation?
ENTA
janice shell janice shell 12 minutes ago
I'm afraid I must take responsibility for that. He was posting about politics on the DD board. I asked him to go do that on one of the politics boards. He complained that as a freebie, he couldn't do that.

So I told him about TA. Perhaps his enthusiasm will wane in time...
JohnnyMakeBucks JohnnyMakeBucks 12 minutes ago
Easy .0015 run from here
IDVV
Ribo Ribo 13 minutes ago
Kuora AI - Luban Large Model + DeepSeek!!🤔😛

https://x.com/eastwin8/status/1887449703324975366
ICNM
JohnnyMakeBucks JohnnyMakeBucks 14 minutes ago
Looks like the funding group has things going on. Nice
IDVV
JohnnyMakeBucks JohnnyMakeBucks 15 minutes ago
Why bother talking so the front loaders can dump. I don’t blame them for not talking.
IDVV
arizona1 arizona1 15 minutes ago
Why would I talk to you?

I have no idea but you just did. #Because MAGAS Are Stupid
Jaguarjacket Jaguarjacket 16 minutes ago
"Think BIG!”
ADIA
Jaguarjacket Jaguarjacket 17 minutes ago
"this is just the beginning. Think BIG!”
ADIA
Jaguarjacket Jaguarjacket 18 minutes ago
"We went public for a reason—this is just the beginning. Think BIG!”
ADIA
Jaguarjacket Jaguarjacket 19 minutes ago
“In the coming weeks, CEO Larry will lay out ADIA’s bold vision for rapid expansion and a clear roadmap toward becoming a national brand. We went public for a reason—this is just the beginning. Think BIG!”
ADIA
Jaguarjacket Jaguarjacket 20 minutes ago
Easily .25+ NextvWeek! So Thin! Let's Goooooo!
ADIA
B402 B402 21 minutes ago
Why would I talk to you?
Lime Time Lime Time 21 minutes ago
Looking forward to the next day, actually. With a leader of a nation. A fighter. A dem would never fight as hard as Trump did. Good lord, can't you see a free country
janice shell janice shell 22 minutes ago
What would you know? I've been a research scholar for my entire adult life. Lots and lots of publications. Most from my academic life. But since I returned to the States, I've been doing financial stuff.

And though you've been here for years, you couldn't figure any of that out. And

Your Recent History

NASDAQ
DXR
Daxor
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads